Mitoxantrone Hydrochloride Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Also known as: CL 232315, DHAD, DHAQ, Dihydroxyanthracenedione Dihydrochloride, Mitoxantrone Dihydrochloride +7 more

Pipeline

Phase 3: 1

Top Sponsors

Children's Oncology Group1

Indications

Acute Myeloid Leukemia1
Cancer1

Birmingham, Alabama1 trial

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Children's Hospital of Alabama

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.